THE ROLE OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF PRIMARY , RECURRENT AND METASTATIC MALIGNANT BRAIN TUMORS

Photodynamic therapy is a relevant and promising area for research in the field of clinical neuroonocology. Application of modern developments in the field of laser technologies and new photosensitizers allows us to refer to this field as to high-tech. According to various authors, the inclusion of photodynamic therapy in combined and complex treatments of patients with malignant brain tumors allows achieving overall survival median of patients from 11 to 26 months for primary form of glioblastoma, and from 7.5 to 15 months – for recurrent forms of glioblastoma. Certain results have been achieved in the treatment of patients with metastatic brain lesion. In this publication the authors analyzed and systematized the results of the main clinical studies in the field of fluorescent diagnostics and intraoperative photodynamic therapy of primary, recurrent and metastatic forms of malignant brain tumors.

[1]  N. Zamboglou,et al.  Salvage therapy for recurrent glioblastoma multiforme: a multimodal approach combining fluorescence-guided resurgery, interstitial irradiation, and chemotherapy , 2014, Neurological research.

[2]  Brian C Wilson,et al.  Photodynamic therapy of brain tumors—A work in progress , 2006, Lasers in surgery and medicine.

[3]  Kathleen Seidel,et al.  Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. , 2012, Neurosurgery.

[4]  C. Wahlestedt,et al.  Emerging treatment strategies for glioblastoma multiforme , 2014, EMBO molecular medicine.

[5]  Barbara Owczarczak,et al.  Photodynamic therapy and anti‐tumor immunity , 2006, Lasers in surgery and medicine.

[6]  Jochen Herms,et al.  5‐Aminolevulinic Acid‐induced Protoporphyrin IX Levels in Tissue of Human Malignant Brain Tumors , 2010, Photochemistry and photobiology.

[7]  A. Brugarolas,et al.  Photodynamic therapy in the treatment of brain tumours. A feasibility study. , 2015, Photodiagnosis and photodynamic therapy.

[8]  M. Dereski,et al.  DEPTH MEASUREMENTS AND HISTOPATHOLOGICAL CHARACTERIZATION OF PHOTODYNAMIC THERAPY GENERATED NORMAL BRAIN NECROSIS AS A FUNCTION OF INCIDENT OPTICAL ENERGY DOSE , 1991, Photochemistry and photobiology.

[9]  A. Kaye,et al.  Modulation of light delivery in photodynamic therapy of brain tumours , 1999, Journal of Clinical Neuroscience.

[10]  A. Kaye,et al.  Photoradiation therapy causing selective tumor kill in a rat glioma model. , 1987, Neurosurgery.

[11]  Michael Lim,et al.  The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy , 2014, Cancers.

[12]  P. Brown,et al.  Properly Selected Patients with Multiple Brain Metastases May Benefit from Aggressive Treatment of their Intracranial Disease , 2004, Journal of Neuro-Oncology.

[13]  Bernhard Olzowy,et al.  Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. , 2002, Journal of neurosurgery.

[14]  E R Laws,et al.  Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissues. , 1983, Neurosurgery.

[15]  B. Wilson,et al.  Photodynamic therapy for recurrent supratentorial gliomas. , 1995, Seminars in surgical oncology.

[16]  G. Jori,et al.  Resistance to Photodynamic Therapy in Cancer , 2015, Resistance to Targeted Anti-Cancer Therapeutics.

[17]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[18]  Thomas S. Mang,et al.  Photodynamic therapy (PDT) for malignant brain tumors--where do we stand? , 2015, Photodiagnosis and photodynamic therapy.

[19]  David Kessel,et al.  Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.

[20]  Mahmoud H. Abdel-Kader,et al.  Photodynamic Therapy: From Theory to Application , 2014 .

[21]  C Rivano,et al.  Fast attempts at the photodynamic treatment of human gliomas. , 1980, Journal of neurosurgical sciences.

[22]  W. Stummer,et al.  Photodynamic therapy within edematous brain tissue: considerations on sensitizer dose and time point of laser irradiation. , 1996, Journal of photochemistry and photobiology. B, Biology.

[23]  Jiro Akimoto,et al.  Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas. , 2012, Photodiagnosis and photodynamic therapy.

[24]  Posner Jb,et al.  Intracranial metastases from systemic cancer. , 1978 .

[25]  Z. Malik,et al.  Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. , 1987, British Journal of Cancer.

[26]  Thomas M. Dimauro.  ALA and Photofrin Fluorescence-Guided Resection And Repetitive PDT In Glioblastoma Multiforme : A Single Centre Phase , 2022 .

[27]  S. Eljamel,et al.  The effects of PDT in primary malignant brain tumours could be improved by intraoperative radiotherapy. , 2012, Photodiagnosis and photodynamic therapy.

[28]  S. Umemura,et al.  Involvement of Reactive Oxygen Species in Sonodynamically Induced Apoptosis Using a Novel Porphyrin Derivative , 2012, Theranostics.

[29]  Hiroshi Iseki,et al.  Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. , 2013, Journal of neurosurgery.

[30]  Jochen Herms,et al.  Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report , 2008, Journal of Neuro-Oncology.

[31]  Andrew H. Kaye,et al.  Photodynamic therapy of high grade glioma – long term survival , 2005, Journal of Clinical Neuroscience.

[32]  C. Brennan,et al.  Emerging therapies for glioblastoma. , 2014, JAMA neurology.

[33]  M. Baptista,et al.  Photodynamic Efficiency: From Molecular Photochemistry to Cell Death , 2015, International journal of molecular sciences.

[34]  B. Wilson,et al.  Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. , 1996, Journal of clinical laser medicine & surgery.

[35]  Herwig Kostron,et al.  Experimental and clinical results of mTHPC (Foscan)-mediated photodynamic therapy for malignant brain tumors , 1998, Photonics West - Biomedical Optics.

[36]  Andreas Obermeier,et al.  Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5‐aminolevulinic acid induced protoporphyrin IX , 2007, Lasers in surgery and medicine.

[37]  M. Kao,et al.  Comparative study on the ALA photodynamic effects of human glioma and meningioma cells , 1999, Lasers in surgery and medicine.

[38]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[39]  Kun Zhang,et al.  Sinoporphyrin sodium, a novel sensitizer, triggers mitochondrial-dependent apoptosis in ECA-109 cells via production of reactive oxygen species , 2014, International journal of nanomedicine.

[40]  N. Hopf,et al.  Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients , 2015, Journal of Neuro-Oncology.

[41]  B. Tromberg,et al.  Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy , 2001, Lasers in surgery and medicine.

[42]  T. Maruyama,et al.  Photodynamic Therapy for Malignant Brain Tumors , 2016 .

[43]  H. Kostron,et al.  Combination of FOSCAN® mediated fluorescence guided resection and photodynamic treatment as new therapeutic concept for malignant brain tumors , 2006 .

[44]  G. Reifenberger,et al.  5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy , 2015, Acta Neurochirurgica.

[45]  T. J. Lewis,et al.  Activated Cancer Therapy Using Light and Ultrasound - A Case Series of Sonodynamic Photodynamic Therapy in 115 Patients over a 4 Year Period , 2009 .

[46]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.